Cartilage Degeneration Market
Cartilage Degeneration Market By Procedure (Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfractures, Meniscus Transplants, Cell-based Cartilage Resurfacing & Other), By Application (Knees, Hips), By Treatment Delivery Channels, By Region- Global Market Insights 2027
Analysis of Cartilage Degeneration Market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Cartilage Degeneration Market Outlook (2022 to 2027)
The global cartilage degeneration market is valued at US$ 12.1 billion in 2022 and is estimated to generate US$ 16 billion in revenue by the end of 2027, and expanding at a CAGR of 5.7% over the next five years.
An increasing number of joint replacement surgeries across the world is expected to drive demand for joint replacements at a CAGR of 6%, which is the highest among all procedures.
| Report Attributes | Details |
|---|---|
| Cartilage Degeneration Market Size (2022) | US$ 12.1 Billion |
| Projected Market Value (2027F) | US$ 16 Billion |
| Global Market Growth Rate (2022 to 2027) | 5.7% CAGR |
| United States Market Value (2022) | US$ 3.4 Billion |
| Canada Market Growth Rate (2022 to 2027) | 4.5% CAGR |
| Joint Replacements Segment Market Value (2027F) | US$ 5.7 Billion |
| Japan Market Growth Rate (2022 to 2027) | 4.8% CAGR |
| China Market Value (2027F) | US$ 2.8 Billion |
| Key Companies Profiled | DePuy Synthes; Zimmer Biomet; Stryker Corporation; Smith & Nephew plc; B. Braun Melsungen AG; Medtronic plc.; Johnson & Johnson (DePuy Synthes); Osiris Therapeutics Inc.; Vericel Corporation; Anika Therapeutics Inc.; MEDIPOST Co. Ltd.; CONMED Corporation; Arthrex Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Cartilage Degeneration Treatment (2017 to 2021) Vs. Market Growth Estimations (2022 to 2027)
Cartilage degeneration leads to many complications and results in bone diseases such as osteoarthritis and the world has witnessed a notable increase in the incidence of such ailments. This trend is expected to be rife across the forecast period as well and is anticipated to primarily drive cartilage degeneration market growth through 2027.
Increasing incidence of accidents and trauma are also anticipated to drive the demand for cartilage repair over the years to come. The increasing geriatric population, rising prevalence of obesity, growing number of sports injuries, and technological advancements in the global cartilage repair market are other factors that influence cartilage degeneration market potential.
However, the high costs of cartilage repair therapies and the lack of favorable reimbursement scenarios in most countries are anticipated to have a restraining effect on the overall market growth going forward.
From 2022 to 2027, the global cartilage degeneration market is slated to exhibit expansion at a moderate CAGR of 5.7%.
What Aspects Will Determine Cartilage Degeneration Market Future?
“Growing Senescent Population & Increase in Sports Injuries Driving Market Progress”
The aging population has been increasing in most parts of the world and this sect of people is more prone to bone diseases and disorders as cartilages degrade over time with age. Countries such as China and the United States are anticipated to witness a notable rise in the geriatric population and emerge as lucrative markets for companies in the cartilage degeneration industry.
People are more involved in outdoor and sports activities than ever before owing to the increasing focus on health and fitness and this has resulted in a rise in sports injuries, which is expected to promulgate cartilage degeneration market potential throughout the forecast period.
“High Costs of Surgeries to Hamper Market Growth”
Bone therapies and surgeries are usually associated with a hefty price tag owing to the use of advanced therapeutics and technologies that increase overall treatment costs. This factor is expected to have a negative impact on cartilage repair/cartilage regeneration market growth across the forecast period. The absence of favorable reimbursement policies is also a prospect that could potentially slow down cartilage degeneration market potential going forward.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Regions Hold a Bright Future for Cartilage Degeneration Treatment Providers?
“North America & Asia Pacific to Provide Highly Attractive Business Scope”
The cartilage degeneration market in North America accounts for a dominant market share at present and is expected to hold its position throughout the forecast period. The presence of developed healthcare infrastructure, favorable reimbursement policies, increasing obesity, rising number of sports injuries, and advancements in cartilage repair treatments are some of the prime factors that are predicted to shape cartilage degeneration market growth in this region.
The Canada cartilage degeneration market is projected to exhibit evolution at a CAGR of 4.5% over the next five years.
The Asia Pacific cartilage degeneration market is anticipated to witness expansion at a higher CAGR than other regions owing to the increasing geriatric population and rising availability of cartilage degeneration treatments. Increasing investments in healthcare infrastructure development, supportive government initiatives, growing geriatric population, and increasing adoption of advanced treatment technologies are other factors that could dictate cartilage degeneration market growth through 2027.
China, India, and Japan are projected to be the key markets in this region across the forecast period. The China cartilage degeneration market is slated to evolve at a 5% CAGR throughout the forecast period to end up with a revenue valuation of US$ 2.8 billion by the end of 2027.
Meanwhile, the market for cartilage degeneration in Japan is anticipated to progress at a CAGR of 4.8% over the coming years. The Europe cartilage degeneration market is also anticipated to be a rewarding market owing to the rising incidence of osteoarthritis and increasing investments in research and development of novel cartilage repair therapeutics.
Fact.MR, a market research and competitive intelligence provider, has created a detailed assessment of opportunities in the cartilage degeneration market in all the major and minor regions in this revised cartilage degeneration market survey.
Country-wise Insights
How Opportune is the U.S. Cartilage Degeneration Market?
“High Prevalence of Obesity Driving Sales of Cartilage Repair & Regeneration Products”
The United States has witnessed a substantial rise in its obese population in recent years and this trend is expected to be prevalent across the forecast period as well. Increasing obesity puts people more at risk of joint pain and joint degeneration resulting in heightened cartilage degeneration. The increasing senescent population in this region is also predicted to favor cartilage degeneration market potential as they are more prone to be affected by bone degeneration.
The increasing availability of cartilage degeneration treatment products and procedures, the presence of developed healthcare infrastructure, and favorable reimbursement policies are other factors that uplift cartilage degeneration market potential through 2027.
The United States cartilage degeneration market in 2022 is valued at US$ 3.4 billion.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Which Procedure is Expected to Lead Overall Market Growth?
“Cartilage Degeneration Market Revenue Led by Rising Joint Replacement Procedures”
The global cartilage degeneration market, based on product, is segmented into joint replacements, chondroplasty, osteochondral transplants, microfracture, meniscus transplants, cell-based cartilage resurfacing, autologous chondrocyte implantation, and others.
Joint replacement procedures account for a lion’s share in the global cartilage degeneration marketplace and are anticipated to maintain this dominant stance across the forecast period owing to the rising number of joint replacement surgeries being performed across the world. High success rates of joint replacement procedures are primarily driving their popularity and are expected to do so through 2027.
- As per statistics provided by the American Academy of Orthopedic Surgeons (AAOS), 90% of the people who have undergone knee replacement surgery witnessed a significant reduction in pain and improvement in physical functioning.
Demand for joint replacement procedures is anticipated to rise at a CAGR of around 6% over the next five years and account for an estimated revenue of US$ 5.7 billion by 2027-end.
What is the Demand Outlook for Knee Cartilage Repair?
“Increasing Number of Knee Surgeries Driving Need for Knee Cartilage Repair”
The global cartilage degeneration market, based on application, is segmented into knees, hips, and others.
Knee injuries have risen in incidence over the past few years and are the most common type of trauma prevagrowing geriatric populationlent in the global marketplace. Advancements in knee replacement surgeries and favorable reimbursement for knee replacement surgeries are also expected to favor knee cartilage repair market growth over the coming years.
Competitive Landscape
Top companies in the cartilage degeneration industry are focusing on creating novel cartilage repair and restoration products to increase their business potential.
- Cytonics, a biotechnology research and development company specializing in therapeutics for osteoarthritis is focusing on creating a blood protein that blocks destructive enzymes that cause degeneration of cartilage tissue. The CYT-108 is an advanced genetically engineered variant of Alpha -2-macroglobulin, a blood protein that helps in cartilage repair by blocking out destructive enzymes.
Companies in the cartilage degeneration market are also focusing on obtaining new approvals for their products to enhance their market presence and drive revenue generation capacity.
- In March 2022, CartiHeal Ltd., an Israel-based developer of implants for the treatment of cartilage defects announced that its Agili-C™ implant was granted Premarket Approval (PMA) by the U.S. FDA (Food and Drug Administration). The approval was based on the results of a two-year IDE clinical study.
Key Segments in Cartilage Degeneration Industry Research
-
By Procedure :
- Joint Replacements
- Chondroplasty
- Osteochondral Transplants
- Microfracture
- Meniscus Transplants
- Cell-based Cartilage Resurfacing
- Autologous Chondrocyte Implantation
- Others
-
By Application :
- Knees
- Hips
- Others
-
By Treatment Delivery Channel :
- Hospitals
- Academic & Research Institutes
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Mn) Analysis 2017 to 2021 and Forecast, 2022 to 2027
- 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, By Procedure
- 6.1. Joint Replacements
- 6.2. Chondroplasty
- 6.3. Osteochondral Transplants
- 6.4. Microfracture
- 6.5. Meniscus Transplants
- 6.6. Cell-based Cartilage Resurfacing
- 6.7. Autologous Chondrocyte Implantation
- 6.8. Others
- 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Application
- 7.1. Knees
- 7.2. Hips
- 7.3. Others
- 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Treatment Delivery Channel
- 8.1. Hospitals
- 8.2. Academic & Research Institutes
- 8.3. Specialty Clinics
- 8.4. Ambulatory Surgical Centers
- 8.5. Others
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 14. South Asia & Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. DePuy Synthes
- 17.2. Zimmer Biomet
- 17.3. Stryker Corporation
- 17.4. Smith & Nephew plc
- 17.5. B. Braun Melsungen AG
- 17.6. Medtronic plc.
- 17.7. Johnson & Johnson (DePuy Synthes)
- 17.8. Osiris Therapeutics Inc.
- 17.9. Vericel Corporation
- 17.10. Anika Therapeutics Inc.
- 17.11. MEDIPOST Co. Ltd.
- 17.12. CONMED Corporation
- 17.13. Arthrex Inc.
- 18. Assumptions and Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Procedure, 2017 to 2021
Table 02: Global Market Value (US$ Mn) Analysis, by Procedure, 2022 to 2027
Table 3: Global Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022 to 2027
Table 04: Global Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 05: Global Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
Table 07: Global Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017 to 2021
Table 80: Global Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022 to 2027
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022 to 2027
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2017 to 2021
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2022 to 2027
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2022 to 2027
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 16: North America Market Value (US$ Mn) Analysis, by Procedure, 2017 to 2021
Table 17: North America Market Value (US$ Mn) Analysis, by Procedure, 2022 to 2027
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022 to 2027
Table 19: North America Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 20: North America Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
Table 22: North America Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017 to 2021
Table 23: North America Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022 to 2027
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022 to 2027
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 28: Latin America Market Value (US$ Mn) Analysis, by Procedure, 2017 to 2021
Table 29: Latin America Market Value (US$ Mn) Analysis, by Procedure, 2022 to 2027
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022 to 2027
Table 31: Latin America Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 32: Latin America Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
Table 34: Latin America Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017 to 2021
Table 35: Latin America Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022 to 2027
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022 to 2027
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 40: Europe Market Value (US$ Mn) Analysis, by Procedure, 2017 to 2021
Table 41: Europe Market Value (US$ Mn) Analysis, by Procedure, 2022 to 2027
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022 to 2027
Table 43: Europe Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 44: Europe Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
Table 46: Europe Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017 to 2021
Table 47: Europe Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022 to 2027
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022 to 2027
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 52: East Asia Market Value (US$ Mn) Analysis, by Procedure, 2017 to 2021
Table 53: East Asia Market Value (US$ Mn) Analysis, by Procedure, 2022 to 2027
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022 to 2027
Table 55: East Asia Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 56: East Asia Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
Table 58: East Asia Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017 to 2021
Table 59: East Asia Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022 to 2027
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022 to 2027
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Procedure, 2017 to 2021
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Procedure, 2022 to 2027
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022 to 2027
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017 to 2021
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022 to 2027
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022 to 2027
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 76: MEA Market Value (US$ Mn) Analysis, by Procedure, 2017 to 2021
Table 77: MEA Market Value (US$ Mn) Analysis, by Procedure, 2022 to 2027
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Procedure, 2022 to 2027
Table 79: MEA Market Value (US$ Mn) Analysis, by Application, 2017 to 2021
Table 80: MEA Market Value (US$ Mn) Analysis, by Application, 2022 to 2027
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2022 to 2027
Table 82: MEA Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2017 to 2021
Table 83: MEA Market Value (US$ Mn) Analysis, by Treatment Delivery Channel, 2022 to 2027
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by Treatment Delivery Channel, 2022 to 2027
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 04: Global Market Incremental $ Opportunity, 2022 to 2027
Figure 05: Global Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 06: Global Market Y-o-Y Growth Projections by Procedure, 2022 to 2027
Figure 07: Global Market Attractiveness Analysis by Procedure, 2022 to 2027
Figure 08: Global Market Share and BPS Analysis by Application, 2022 & 2027
Figure 09: Global Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 10: Global Market Attractiveness Analysis by Application, 2022 to 2027
Figure 11: Global Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 12: Global Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022 to 2027
Figure 13: Global Market Attractiveness Analysis by Treatment Delivery Channel, 2022 to 2027
Figure 14: Global Market Share and BPS Analysis by Region, 2022 & 2027
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2022 to 2027
Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2027
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2022 to 2027
Figure 20: North America Market Incremental $ Opportunity, 2022 to 2027
Figure 21: North America Market Share Analysis by Country, 2022 & 2027
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 23: North America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 24: North America Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 25: North America Market Y-o-Y Growth Projections by Procedure, 2022 to 2027
Figure 26: North America Market Attractiveness Analysis by Procedure, 2022 to 2027
Figure 27: North America Market Share and BPS Analysis by Application, 2022 & 2027
Figure 28: North America Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 29: North America Market Attractiveness Analysis by Application, 2022 to 2027
Figure 30: North America Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 31: North America Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022 to 2027
Figure 32: North America Market Attractiveness Analysis by Treatment Delivery Channel, 2022 to 2027
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 36: Latin America Market Incremental $ Opportunity, 2022 to 2027
Figure 37: Latin America Market Share Analysis by Country, 2022 & 2027
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 39: Latin America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 40: Latin America Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 41: Latin America Market Y-o-Y Growth Projections by Procedure, 2022 to 2027
Figure 42: Latin America Market Attractiveness Analysis by Procedure, 2022 to 2027
Figure 43: Latin America Market Share and BPS Analysis by Application, 2022 & 2027
Figure 44: Latin America Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 45: Latin America Market Attractiveness Analysis by Application, 2022 to 2027
Figure 46: Latin America Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 47: Latin America Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022 to 2027
Figure 48: Latin America Market Attractiveness Analysis by Treatment Delivery Channel, 2022 to 2027
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 52: Europe Market Incremental $ Opportunity, 2022 to 2027
Figure 53: Europe Market Share Analysis by Country, 2022 & 2027
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 55: Europe Market Attractiveness Analysis by Country, 2022 to 2027
Figure 56: Europe Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 57: Europe Market Y-o-Y Growth Projections by Procedure, 2022 to 2027
Figure 58: Europe Market Attractiveness Analysis by Procedure, 2022 to 2027
Figure 59: Europe Market Share and BPS Analysis by Application, 2022 & 2027
Figure 60: Europe Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 61: Europe Market Attractiveness Analysis by Application, 2022 to 2027
Figure 62: Europe Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 63: Europe Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022 to 2027
Figure 64: Europe Market Attractiveness Analysis by Treatment Delivery Channel, 2022 to 2027
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 68: East Asia Market Incremental $ Opportunity, 2022 to 2027
Figure 69: East Asia Market Share Analysis by Country, 2022 & 2027
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 71: East Asia Market Attractiveness Analysis by Country, 2022 to 2027
Figure 72: East Asia Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 73: East Asia Market Y-o-Y Growth Projections by Procedure, 2022 to 2027
Figure 74: East Asia Market Attractiveness Analysis by Procedure, 2022 to 2027
Figure 75: East Asia Market Share and BPS Analysis by Application, 2022 & 2027
Figure 76: East Asia Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 77: East Asia Market Attractiveness Analysis by Application, 2022 to 2027
Figure 78: East Asia Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 79: East Asia Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022 to 2027
Figure 80: East Asia Market Attractiveness Analysis by Treatment Delivery Channel, 2022 to 2027
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2022 to 2027
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2022 & 2027
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2022 to 2027
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Procedure, 2022 to 2027
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Procedure, 2022 to 2027
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Application, 2022 & 2027
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Application, 2022 to 2027
Figure 94: South Asia & Oceania Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022 to 2027
Figure 96: South Asia & Oceania Market Attractiveness Analysis by Treatment Delivery Channel, 2022 to 2027
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 100: MEA Market Incremental $ Opportunity, 2022 to 2027
Figure 101: MEA Market Share Analysis by Country, 2022 & 2027
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 103: MEA Market Attractiveness Analysis by Country, 2022 to 2027
Figure 104: MEA Market Share and BPS Analysis by Procedure, 2022 & 2027
Figure 105: MEA Market Y-o-Y Growth Projections by Procedure, 2022 to 2027
Figure 106: MEA Market Attractiveness Analysis by Procedure, 2022 to 2027
Figure 107: MEA Market Share and BPS Analysis by Application, 2022 & 2027
Figure 108: MEA Market Y-o-Y Growth Projections by Application, 2022 to 2027
Figure 109: MEA Market Attractiveness Analysis by Application, 2022 to 2027
Figure 110: MEA Market Share and BPS Analysis by Treatment Delivery Channel, 2022 & 2027
Figure 111: MEA Market Y-o-Y Growth Projections by Treatment Delivery Channel, 2022 to 2027
Figure 112: MEA Market Attractiveness Analysis by Treatment Delivery Channel, 2022 to 2027
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the outlook for joint replacements as per this Fact.MR report?
Joint replacement procedures are anticipated to account for US$ 5.7 billion by the end of 2027.
What is the estimated valuation of the cartilage degeneration market for 2027?
By 2027, the global market for cartilage degeneration is slated to reach US$ 16 billion.
What is the growth rate of the cartilage degeneration market?
The global cartilage degeneration market is predicted to steadily evolve at 5.7% CAGR through 2027.
How does this Fact.MR research characterize the market in China?
The market in China is predicted to expand at 6% CAGR and account for a value of US$ 2.8 billion by 2027.
What is the current revenue of the cartilage degeneration market?
Currently, the global cartilage degeneration market stands at US$ 12.1 billion.
Which is the leading regional market for cartilage degeneration?
North America leads the global market and accounts for a valuation of US$ 3.4 billion in 2022.
Who are the major companies operating in the cartilage degeneration market?
Medtronic plc., Johnson & Johnson (DePuy Synthes), Osiris Therapeutics Inc., Vericel Corporation, Anika Therapeutics Inc., MEDIPOST Co. Ltd., CONMED Corporation, and Arthrex Inc. are major companies dealing in cartilage degeneration treatment products.
Cartilage Degeneration Market